Northland Capital Appointed as Joint Broker

20th June 2016 - 2:02 pm

ImmuPharma PLC (LSE:IMM), (“ImmuPharma” or the “Company”), the specialist drug discovery and development company, announces the appointment of Northland Capital Partners as joint broker to the Company, alongside Panmure Gordon with immediate effect.

Share this article

Leave a comment